HERO IMAGE FRANCISCO

Restoring youth and enhancing form

By Dr Francisco De Melo

Today, we understand more about the ageing process than ever before, and the latest scientific evidence gives us unique insight and new ways in which to manage this natural transition.

Hear from Dr Francisco

The structural elements

Plastic surgeons, dermatologists and cosmetic physicians around the world are using techniques to slow down or reverse some of the effects of time. In this respect, we focus on structural elements - which is mainly centred on volume.

View patient testimonials
Model is not an actual patient.
Square Image 05

Restoring Youth

The Importance of Volume

As we age, we lose volume due to atrophy of bone and fat. This, in turn, leaves the face looking older, with the bone structure becoming more prominent and skeletal. Skin starts to sag, and the folds around the nose and mouth become deeper. However, once we replace this loss of volume, these effects are partially - or almost wholly - corrected, depending on other individual factors.
03
Model is not an actual patient.

A New Class of Filler

The majority of fillers on the market are hyaluronic acid-based, which means they just replace volume without effective long-term results. ELLANSÉ belongs to a new class of fillers that deliver immediate results (thanks to their volumising capacity), as well as longer-term benefits from the formation of new collagen (through a process called neocollagenesis).
02
Model is not an actual patient.

Collagen and volume

This newly-formed collagen increases volume for a long period of time. In my experience, it also improves the soft tissue and skin quality and elasticity, without feeling fake or like a foreign element to the body. Furthermore, due to the qualities of the Polycaprolactone (PLC) microspheres, ELLANSÉ has adjustable longevity, thereby ensuring clinical results that last from 18 months to 3 years.*
05
Model is not an actual patient.

Better Balance

Another valuable characteristic of ELLANSÉ is that it also allows us to change the proportion and shape of certain facial features. We can create a more balanced face - a more desirable ratio between the features and its overall structure - while avoiding more invasive procedures like the surgical placement of cheek or chin implants.
07
Model is not an actual patient.

Safety and Satisfaction

Speaking personally, and on behalf of my patients, the filler’s safety profile is the most crucial element. So I’m pleased to say that ELLANSÉ has an excellent safety record, with minimal adverse effects reported to date. ELLANSÉ is my filler of choice because it allows me to offer safe treatments, consistently deliver excellent and long-lasting results, and ensure exceptional patient satisfaction.
08
Model is not an actual patient.
We can create a more balanced face - a more desirable ratio between the features and its overall structure.
Clinic Finder Banner

Find your clinic

Search your location or postcode to find a physician near you

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Pharma Corporate Safety Group: quality@sinclairpharma.com